2nd Annual China’s Position in Global Manufacturing: A Comparison of China’s Emerging Position vs Established Regions’ Manufacturing Capacity and Production
An in-depth review of emerging trends and opportunities, with comparative data from BioPlan’s 20th Annual Report and Survey of Biopharmaceutical Manufacturing. This analysis will help decision makers understand the changing China biopharmaceutical industry to make strategic decisions on why and when they should enter the China market.
- Introduction
- Research Methodology
- 1 - Single Most Important Biomanufacturing Trend/Operational Area Industry Must Focus Efforts for 2023
- 2 - Novel Bioprocessing Systems/Innovations Facilities Plan to Evaluate in the Next 12 Months
- 3 - Average Cost for Facility’s Primary Recombinant Protein Manufactured at Facility (per gram)
- 4 - Range and Averages of Titers for mAbs Obtained at Various Production Scales
- 5 - Current Percent of Total Capacity for Facility Operation, by Production System
- 6 - Production Capacity Constraints for Facilities Today
- 7 - Downstream Bioprocessing Steps Creating Overall Capacity Constraints
- 8 - Areas to Address for Industry to Avoid Significant Capacity Constraints
- 9 - Budget and Funding Percentage Changes Over the Next 12 Months
- 10 - Actions to Reduce Overall Bioprocessing Costs During the Past 12 Months
- 11 - Percentage of Facilities’ Unit Operations that are “Single-Use or Disposable”
- 12 - Change in Spending on OUTSOURCING for R&D or Manufacturing in the Next 12 Months
- 13 - Current Outsourcing for the Following Activities by Facilities
- 14 - Top NEW Bioprocessing Expenditures in the Past Year"
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook